Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Feucht

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Cancer Immunology, Immunotherapy : CII|April 2, 2018
Induction of a central memory and stem cell memory phenotype in functionally active CD4<sup>+</sup> and CD8<sup>+</sup> CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19<sup>+</sup> acute lymphoblastic leukemiaFranziska Blaeschke, Dana Stenger, Theresa Kaeuferle, et al.
Nature Medicine|December 19, 2018
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencyJudith Feucht, Jie Sun, Justin Eyquem, et al.
Medical Mycology|October 21, 2015
Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantationWerner J Heinz, Karin M Cabanillas Stanchi, Hartwig Klinker, et al.
Journal of Cancer Research and Clinical Oncology|August 26, 2019
Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patientsKarin Melanie Cabanillas Stanchi, Manon Queudeville, Carmen Malaval, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2017
Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantationMichaela Döring, Karin Melanie Cabanillas Stanchi, Manon Queudeville, et al.
Nature|February 9, 2023
TET2 guards against unchecked BATF3-induced CAR T cell expansionNayan Jain, Zeguo Zhao, Judith Feucht, et al.
Haematologica|April 15, 2014
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomabPatrick Schlegel, Peter Lang, Gerhard Zugmaier, et al.
Blood|February 6, 2023
Novel extragenic genomic safe harbors for precise therapeutic T-cell engineeringAshlesha Odak, Han Yuan, Judith Feucht, et al.
Medical Mycology|October 6, 2016
Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropeniaMichaela Döring, Karin Melanie Cabanillas Stanchi, Hartwig Klinker, et al.
Oncotarget|October 7, 2016
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blastsJudith Feucht, Simone Kayser, David Gorodezki, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|April 2, 2018
Induction of a central memory and stem cell memory phenotype in functionally active CD4<sup>+</sup> and CD8<sup>+</sup> CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19<sup>+</sup> acute lymphoblastic leukemiaFranziska Blaeschke, Dana Stenger, Theresa Kaeuferle, et al.
Nature Medicine|December 19, 2018
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencyJudith Feucht, Jie Sun, Justin Eyquem, et al.
Medical Mycology|October 21, 2015
Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantationWerner J Heinz, Karin M Cabanillas Stanchi, Hartwig Klinker, et al.
Journal of Cancer Research and Clinical Oncology|August 26, 2019
Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patientsKarin Melanie Cabanillas Stanchi, Manon Queudeville, Carmen Malaval, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2017
Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantationMichaela Döring, Karin Melanie Cabanillas Stanchi, Manon Queudeville, et al.
Nature|February 9, 2023
TET2 guards against unchecked BATF3-induced CAR T cell expansionNayan Jain, Zeguo Zhao, Judith Feucht, et al.
Haematologica|April 15, 2014
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomabPatrick Schlegel, Peter Lang, Gerhard Zugmaier, et al.
Blood|February 6, 2023
Novel extragenic genomic safe harbors for precise therapeutic T-cell engineeringAshlesha Odak, Han Yuan, Judith Feucht, et al.
Medical Mycology|October 6, 2016
Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropeniaMichaela Döring, Karin Melanie Cabanillas Stanchi, Hartwig Klinker, et al.
Oncotarget|October 7, 2016
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blastsJudith Feucht, Simone Kayser, David Gorodezki, et al.
Pageof 5